Can the US cut drug prices without sacrificing new
cures?
https://www.vox.com/policy-and-politics/22702855/build-build-better-plan-medicare-negotiate-drug-prices
https://www.vox.com/policy-and-politics/22702855/build-build-better-plan-medicare-negotiate-drug-prices
Drug Prices by Committee: One Way Biden Could Lower Costs
Many countries use independent review boards to balance innovation and profit.
https://www.nytimes.com/2021/02/11/upshot/biden-drug-prices.html
Drug Innovation: When Patents Work (and When They
Don’t)
https://www.milkenreview.org/articles/drug-innovation-when-patents-work
In recent years, drug makers have developed a host of dazzling products, including some based on cutting-edge gene therapy technology. Given the difficulties (scientific, financial and regulatory) of developing these new technologies and bringing them to market, pharmas argue that strong patent protection is essential if we expect innovation to continue at the current pace. Or maybe not. Fundamental shifts in the technology behind drug development suggest there are alternative ways for ensuring that successful innovators recoup their investments. And in light of the societal costs that are part and parcel of protecting intellectual property with patents, it’s worth asking whether this form of protection sometimes does more harm than good.
Our patent system is broken. And it could be
stifling innovation.
Are drug patents worth it? | The Economist
https://www.economist.com/business/2021/05/15/are-drug-patents-worth-it
Many countries use independent review boards to balance innovation and profit.
https://www.nytimes.com/2021/02/11/upshot/biden-drug-prices.html
https://www.milkenreview.org/articles/drug-innovation-when-patents-work
In recent years, drug makers have developed a host of dazzling products, including some based on cutting-edge gene therapy technology. Given the difficulties (scientific, financial and regulatory) of developing these new technologies and bringing them to market, pharmas argue that strong patent protection is essential if we expect innovation to continue at the current pace. Or maybe not. Fundamental shifts in the technology behind drug development suggest there are alternative ways for ensuring that successful innovators recoup their investments. And in light of the societal costs that are part and parcel of protecting intellectual property with patents, it’s worth asking whether this form of protection sometimes does more harm than good.
https://www.economist.com/business/2021/05/15/are-drug-patents-worth-it
--
The Real Reason the U.S. Has Employer-Sponsored
Health Insurance
https://www.nytimes.com/2017/09/05/upshot/the-real-reason-the-us-has-employer-sponsored-health-insurance.html
Putting a Dollar Value on Life? Governments Already
Do
https://www.nytimes.com/2020/05/11/upshot/virus-price-human-life.html
https://www.nytimes.com/2017/09/05/upshot/the-real-reason-the-us-has-employer-sponsored-health-insurance.html
https://www.nytimes.com/2020/05/11/upshot/virus-price-human-life.html
Failing public health is killing Americans,
unequally
https://thehill.com/opinion/healthcare/576999-failing-public-health-is-killing-americans-unequally
https://thehill.com/opinion/healthcare/576999-failing-public-health-is-killing-americans-unequally